137 related articles for article (PubMed ID: 32851272)
1. Analysis of the short-term curative effect of 356 cases of intraocular retinoblastoma in children.
Jin M; Zhao J; Zhang D; Zhang C; Zhao W; Wang X; Zhao Q; Duan C; Su Y; Hong H; Ma X
Pediatr Investig; 2018 Dec; 2(4):236-241. PubMed ID: 32851272
[TBL] [Abstract][Full Text] [Related]
2. Bilateral enucleation for retinoblastoma: A study of 14 patients.
Machakuri K; Kaliki S
Oman J Ophthalmol; 2022; 15(2):188-192. PubMed ID: 35937719
[TBL] [Abstract][Full Text] [Related]
3. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome.
Russo I; Levy-Gabriel C; Dupont A; Lumbroso-Le Rouic L; Cassoux N; Desjardins L; Bertozzi AI; Coze C; Doz F; Savignoni A; Aerts I
Pediatr Blood Cancer; 2021 Jan; 68(1):e28721. PubMed ID: 33098751
[TBL] [Abstract][Full Text] [Related]
4. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
[TBL] [Abstract][Full Text] [Related]
5. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).
Jubran RF; Villablanca JG; Krailo M; Piao J; Huang L; Murphree AL; O'Brien J; Gombos D; Shields CL; Meadows A; Chintagumpala M
Pediatr Blood Cancer; 2020 Sep; 67(9):e28502. PubMed ID: 32589362
[TBL] [Abstract][Full Text] [Related]
6. A 20-year audit of retinoblastoma treatment outcomes.
Gündüz AK; Mirzayev I; Temel E; Ünal E; Taçyıldız N; Dinçaslan H; Köse SK; Özalp Ateş FS; Işık MU
Eye (Lond); 2020 Oct; 34(10):1916-1924. PubMed ID: 32376976
[TBL] [Abstract][Full Text] [Related]
7. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
[TBL] [Abstract][Full Text] [Related]
8. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
9. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country.
Chantada GL; Fandiño AC; Raslawski EC; Manzitti J; de Dávila MT; Casak SJ; Scopinaro MJ; Schvartzman E
Pediatr Blood Cancer; 2005 May; 44(5):455-60. PubMed ID: 15558702
[TBL] [Abstract][Full Text] [Related]
10. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
Sultan I; Hajja Y; Nawaiseh I; Mehyar M; Deebajah R; Jaradat I; Yousef YA
Ophthalmic Genet; 2016 Jun; 37(2):209-13. PubMed ID: 26760494
[TBL] [Abstract][Full Text] [Related]
11. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
[TBL] [Abstract][Full Text] [Related]
12. Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma.
Brennan RC; Qaddoumi I; Mao S; Wu J; Billups CA; Stewart CF; Hoehn ME; Rodriguez-Galindo C; Wilson MW
J Clin Oncol; 2017 Jan; 35(1):72-77. PubMed ID: 28034080
[TBL] [Abstract][Full Text] [Related]
13. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
Mirzayev I; Gündüz AK; Yavuz K; Şekkeli MZ; Özalp Ateş FS; Ünal E; Taçyıldız N
Eur J Ophthalmol; 2021 Sep; 31(5):2692-2698. PubMed ID: 32962409
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
[TBL] [Abstract][Full Text] [Related]
15. The success of primary chemotherapy for group D heritable retinoblastoma.
Cohen VM; Kingston J; Hungerford JL
Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
[TBL] [Abstract][Full Text] [Related]
16. Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma.
Choi S; Han JW; Kim H; Kim BS; Kim DJ; Lee SC; Lyu CJ
Korean J Pediatr; 2013 Jun; 56(6):254-9. PubMed ID: 23807892
[TBL] [Abstract][Full Text] [Related]
17. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Greenwald MJ; Strauss LC
Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
[TBL] [Abstract][Full Text] [Related]
18. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
Ye H; Du Y; Chen R; Luo X; Mao Y; Ai S; Ma W; Ding Y; Li Q; Yang H
Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
[TBL] [Abstract][Full Text] [Related]
19. Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.
Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brennan RC; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa-Llano G; Carreras E;
Ophthalmology; 2022 Aug; 129(8):933-945. PubMed ID: 35500608
[TBL] [Abstract][Full Text] [Related]
20. Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy.
Yousef YA; Nazzal RM; Khalil MB; Deebajah R; Mehyar M; Hajja S; Mohammad M; Al Jabary R; Jaradat I; Sultan I; Al Nawaiseh I
Oman J Ophthalmol; 2017; 10(2):70-75. PubMed ID: 28757689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
